Othmar G Engelhardt
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 23, 2022
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies.Chung Y Cheung, Sitara Dubey, Martina Hadrovic
|Apr 03, 2021
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.Andrew Tung Yep, Yasu Takeuchi, Othmar G Engelhardt
|Aug 12, 2020
Inactivated pandemic 2009 H1N1 influenza A virus human vaccines have different efficacy after homologous challenge in the ferret model.Beatriz Vidaña, Sharon M Brookes, Helen E Everett
|Dec 15, 2019
Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.Florian Krammer, Jerry P Weir, Othmar Engelhardt
|Oct 30, 2019
Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.Li-Mei Chen, Ruben O Donis, David L Suarez
|Feb 02, 2017
Workshop report: Immunoassay standardisation for "universal" influenza vaccines.Sophia Pavlova, Flavia D'Alessio, Sophie Houard
Pageof 1
